Silvia Mosti

789 total citations
23 papers, 297 citations indexed

About

Silvia Mosti is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Silvia Mosti has authored 23 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 11 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Silvia Mosti's work include Tuberculosis Research and Epidemiology (10 papers), COVID-19 Clinical Research Studies (7 papers) and Mycobacterium research and diagnosis (4 papers). Silvia Mosti is often cited by papers focused on Tuberculosis Research and Epidemiology (10 papers), COVID-19 Clinical Research Studies (7 papers) and Mycobacterium research and diagnosis (4 papers). Silvia Mosti collaborates with scholars based in Italy, United States and United Kingdom. Silvia Mosti's co-authors include Gina Gualano, Fabrizio Palmieri, Delia Goletti, Maria Musso, Enrico Girardi, Francesco Di Gennaro, Pietro Vittozzi, Paola Mencarini, Raffaella Libertone and Antonino Di and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and BMC Infectious Diseases.

In The Last Decade

Silvia Mosti

19 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvia Mosti Italy 10 237 81 65 26 23 23 297
Raffaella Libertone Italy 11 217 0.9× 119 1.5× 41 0.6× 20 0.8× 10 0.4× 29 332
M Marshall United States 4 194 0.8× 98 1.2× 103 1.6× 11 0.4× 47 2.0× 15 378
Silvia Amadasi Italy 7 111 0.5× 90 1.1× 30 0.5× 48 1.8× 48 2.1× 15 238
John E. McKinnon United States 13 217 0.9× 51 0.6× 39 0.6× 20 0.8× 22 1.0× 34 530
Lumine Na Australia 8 145 0.6× 31 0.4× 54 0.8× 19 0.7× 22 1.0× 12 312
Mehrdad Hasibi Iran 10 101 0.4× 46 0.6× 80 1.2× 11 0.4× 40 1.7× 38 273
Nicola Schiano Moriello Italy 11 159 0.7× 104 1.3× 21 0.3× 7 0.3× 23 1.0× 27 266
A. Zimmer Canada 9 167 0.7× 102 1.3× 40 0.6× 30 1.2× 22 1.0× 16 267
Carlos Dueñas Spain 10 159 0.7× 73 0.9× 34 0.5× 5 0.2× 8 0.3× 29 236

Countries citing papers authored by Silvia Mosti

Since Specialization
Citations

This map shows the geographic impact of Silvia Mosti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Mosti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Mosti more than expected).

Fields of papers citing papers by Silvia Mosti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Mosti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Mosti. The network helps show where Silvia Mosti may publish in the future.

Co-authorship network of co-authors of Silvia Mosti

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Mosti. A scholar is included among the top collaborators of Silvia Mosti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Mosti. Silvia Mosti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gualano, Gina, Pietro Vittozzi, Virginia Di Bari, et al.. (2025). A Case of Pulmonary Fibrosis and COVID-19-Related Pneumonia in a Pembrolizumab-Treated Patient. Infectious Disease Reports. 17(3). 53–53.
2.
Gualano, Gina, Paola Mencarini, Carlotta Cerva, et al.. (2025). Diagnostic yield of induced sputum and Bronchoalveolar lavage in suspected pulmonary tuberculosis. BMC Infectious Diseases. 25(1). 680–680.
3.
4.
Mencarini, Paola, S. Carli, Carlotta Cerva, et al.. (2024). Clinical Utility of Induced Sputum and Bronchoalveolar Lavage Cultures in Diagnosing Nontuberculous Mycobacterial Pulmonary Disease. Pathogens. 13(12). 1064–1064. 1 indexed citations
5.
6.
Guido, Giacomo, Eleonora Lalle, Silvia Mosti, et al.. (2023). Recovery from Triple Infection with SARS-CoV-2, RSV and Influenza virus: A case report. Journal of Infection and Public Health. 16(7). 1045–1047. 1 indexed citations
7.
Bari, Virginia Di, Gina Gualano, Maria Musso, et al.. (2022). Increased Association of Pulmonary Thromboembolism and Tuberculosis during COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital. Antibiotics. 11(3). 398–398. 3 indexed citations
8.
Vita, Serena, Simone Lanini, Pierluca Piselli, et al.. (2021). Benefits of Steroid Therapy in COVID-19 Patients with Different PaO2/FiO2 Ratio at Admission. Journal of Clinical Medicine. 10(15). 3236–3236. 3 indexed citations
9.
Musso, Maria, Francesco Di Gennaro, Gina Gualano, et al.. (2021). Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy. Infection. 49(5). 1061–1064. 22 indexed citations
10.
Biliotti, Elisa, Pierluca Piselli, Raffaella Lionetti, et al.. (2021). The Fibrosis-4 index is associated with Intensive Care Unit (ICU) admission in middle-aged patients with COVID-19. Digestive and Liver Disease. 53. S21–S22. 1 indexed citations
11.
Grassi, Germana, Valentina Vanini, Federica De Santis, et al.. (2021). PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease. Frontiers in Immunology. 12. 594376–594376. 11 indexed citations
12.
Mencarini, Paola, Alessandra Scarabello, Franca Del Nonno, et al.. (2021). Dermatological manifestations during COVID‐19 and histological picture: Description of two clinical cases. The Journal of Dermatology. 48(5). 651–656. 3 indexed citations
13.
Aiello, Alessandra, Saeid Najafi Fard, Elisa Petruccioli, et al.. (2021). Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients. International Journal of Infectious Diseases. 106. 338–347. 31 indexed citations
14.
Gualano, Gina, Maria Musso, Silvia Mosti, et al.. (2020). Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report. International Journal of Infectious Diseases. 97. 174–176. 22 indexed citations
15.
Gennaro, Francesco Di, Pietro Vittozzi, Gina Gualano, et al.. (2020). Active Pulmonary Tuberculosis in Elderly Patients: A 2016–2019 Retrospective Analysis from an Italian Referral Hospital. Antibiotics. 9(8). 489–489. 47 indexed citations
16.
Musso, Maria, Silvia Mosti, Gina Gualano, et al.. (2019). Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis. BMC Infectious Diseases. 19(1). 882–882. 10 indexed citations
17.
18.
Gualano, Gina, Paola Mencarini, Maria Musso, et al.. (2019). Putting in Harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for Multidrug-Resistant Tuberculosis. PA4567–PA4567. 4 indexed citations
19.
Pinnetti, Carmela, Patrizia Lorenzini, Rita Bellagamba, et al.. (2014). Relationship between body mass index and bone mineral density in HIV‐infected patients referred for DXA. Journal of the International AIDS Society. 17(4S3). 19569–19569. 9 indexed citations
20.
Zaccarelli, Mauro, Ubaldo Visco‐Comandini, Grazia Maria Liuzzi, et al.. (2007). Evidence of Dual Sexual Transmission of Multi-resistant HIV with Two Years Persistence of Resistance to NRTI and NNRTI: a Case Report. Infection. 36(2). 178–180. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raffaella Libertone Breakdown of academic impact, for papers by M Marshall Breakdown of academic impact, for papers by Silvia Amadasi Breakdown of academic impact, for papers by John E. McKinnon Breakdown of academic impact, for papers by Lumine Na Breakdown of academic impact, for papers by Mehrdad Hasibi Breakdown of academic impact, for papers by Nicola Schiano Moriello Breakdown of academic impact, for papers by A. Zimmer Breakdown of academic impact, for papers by Carlos Dueñas
Rankless by CCL
2026